Emyria Limited (ASX:EMD)
0.0580
-0.0040 (-6.45%)
At close: Jan 22, 2026
Emyria Market Cap
Emyria has a market cap or net worth of 46.77 million as of January 22, 2026. Its market cap has increased by 182.08% in one year.
Market Cap
46.77M
Enterprise Value
43.82M
Revenue
1.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since February 12, 2020, Emyria's market cap has increased from 26.67M to 46.77M, an increase of 75.41%. That is a compound annual growth rate of 9.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 50.00M | 5.37% |
| Dec 31, 2025 | 47.45M | 203.01% |
| Dec 30, 2024 | 15.66M | -17.86% |
| Dec 29, 2023 | 19.06M | -61.44% |
| Dec 30, 2022 | 49.44M | -53.29% |
| Dec 31, 2021 | 105.86M | 410.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alcidion Group | 161.15M |
| Mach7 Technologies | 124.53M |
| BlinkLab | 122.76M |
| Singular Health Group | 81.63M |
| PharmX Technologies | 80.93M |
| PainChek | 59.57M |
| Beamtree Holdings | 55.21M |
| Vitasora Health | 42.74M |